33 Results

People

  1. Gupta
    Gupta
  2. Park
    Park
  3. Perales
    Perales
  4. Dahi
    Dahi
  5. Mailankody
    Mailankody
  6. Palomba
    Palomba
  7. Scordo
    Scordo
  8. Shah
    Shah
  9. Shouval
    Shouval
  10. Usmani
    Usmani

Groups

  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (17)
  4. Bone Marrow Transplant (8)
  5. Department of Pathology and Laboratory Medicine (8)
  6. Adult Leukemia (7)
  7. CTCR Scholars (5)
  8. Survivorship Research (5)
  9. Biostatistics Service (4)
  10. Epidemiology and Biostatistics (4)
  1. "apheresis"
Formats
  1. Journal Article (26)
  2. Review (4)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (18)
  2. Hematologic Malignancies, Division of (18)
  3. Center for Hematologic Malignancies (17)
  4. Bone Marrow Transplant (8)
  5. Department of Pathology and Laboratory Medicine (8)
  6. Adult Leukemia (7)

More Groups

People
  1. Gaurav Gupta (4)
  2. Jae Park (4)
  3. Miguel-Angel Perales (4)
  4. Sean Devlin (4)
  5. Gunjan Shah (3)
  6. Maria Palomba (3)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (3)
  4. 2022 (5)
  5. 2021 (1)
  6. 2019 (2)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Blood Advances (3)
  3. Transfusion (3)
  4. Haematologica (2)
  5. Journal of Clinical Oncology (2)
  6. Journal of the National Comprehensive Cancer Network (2)

More Publications

Publishers
  1. Elsevier Inc. (6)
  2. American Society of Hematology (4)
  3. Blackwell Publishing (3)
  4. American Society of Clinical Oncology (2)
  5. Biomed Central Ltd (2)
  6. Ferrata Storti Foundation (2)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 clinical trial of B-cell maturation antigen (BCMA) NEX-T® chimeric antigen receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
    Journal Article

    Ravi, G.; Richard, S.; Kumar, S.; Atrash, S.; Liedtke, M.; Kaur, G.; Derman, B.; Bergsagel, P. L.; Mailankody, S.; McCarthy, P.; more...
    Leukemia (2025)

    Fulltext@MSK | Save
  • Outcomes after brexucabtagene autoleucel administered as a standard therapy for adults with relapsed/refractory B-cell ALL
    Journal Article

    Roloff, G. W.; Aldoss, I.; Kopmar, N. E.; Lin, C.; Dekker, S. E.; Gupta, V. K.; O’Connor, T. E.; Jeyakumar, N.; Muhsen, I. N.; Valtis, Y.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Accelerating accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?
    Review

    Rajeeve, S.; Hoskote, A.; Mailankody, S.
    Seminars in Hematology (2024)

    Fulltext@MSK | Save
  • Platelet transfusions in adult ICU patients with thrombocytopenia: A sub-study of the PLOT-ICU inception cohort study
    Journal Article

    Anthon, C. T.; Pène, F.; Perner, A.; Azoulay, E.; Puxty, K.; Van De Louw, A.; Chawla, S.; Castro, P.; Povoa, P.; Coelho, L.; more...
    Acta Anaesthesiologica Scandinavica (2024)

    Fulltext@MSK | Save
  • Immature platelet count responses of pediatric patients with immune-mediated thrombotic thrombocytopenic purpura
    Research Letter

    Reeves, H. M.; Zhu, M. L.; Maitta, R. W.
    Thrombosis Research (2024)

    Fulltext@MSK | Save
  • Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7
    Journal Article

    Ghobadi, A.; Munoz, J.; Westin, J. R.; Locke, F. L.; Miklos, D. B.; Rapoport, A. P.; Perales, M. A.; Reagan, P. M.; McGuirk, J.; Jacobson, C. A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
    Journal Article

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Zheng, J.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; more...
    Journal of Hematology & Oncology (2024)

    Fulltext@MSK | Save